A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis

Completed

Plain-English translation of NCT03653026 on ClinicalTrials.gov ↗ · Source last updated March 2022 · How we translate trials

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(379 sites)

United States

East View Medical Research, LLC /ID# 216933, Mobile, Alabama

CB Flock Research Corporation /ID# 206094, Mobile, Alabama

Arizona Arthritis & Rheumatology Research, PLLC /ID# 211030, Sun City, Arizona

Digestive Disease Consultants, A Division of Arizona Digestive Health, P.C /ID# 211887, Tempe, Arizona

University of Arizona /ID# 208856, Tucson, Arizona